CALRECIA

This brand name is authorized in Austria, Croatia, Ecuador, Estonia, Finland, Ireland, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug CALRECIA contains one active pharmaceutical ingredient (API):

1	Calcium chloride UNII M4I0D6VV5M - CALCIUM CHLORIDE
	Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.
	Read more about Calcium chloride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CALRECIA Solution for infusion	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05XA07	Calcium chloride	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions
Discover more medicines within B05XA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	7308-MEE-0622
EE	Ravimiamet	1746817
ES	Centro de información online de medicamentos de la AEMPS	83899
FI	Lääkealan turvallisuus- ja kehittämiskeskus	453518
GB	Medicines & Healthcare Products Regulatory Agency	386240
HR	Agencija za lijekove i medicinske proizvode	HR-H-607342947
LT	Valstybinė vaistų kontrolės tarnyba	1086837
PL	Rejestru Produktów Leczniczych	100389549
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65758001